New gene-editing system enables large-scale studies of gene function.
The Center for Biomedical Innovation at MIT will host a roundtable discussion, "Improving Drug Safety: Critical Elements of a 'Learning Healthcare System,'" at 2 p.m. Oct. 23 at the Royal Sonesta Hotel in Cambridge. The event is free and open to the public.
Presented in collaboration with MIT's Engineering Systems Division and the New England Healthcare Institute, participants in the discussion include Dr. Mark McClellan, director of the Engelberg Center for Health Care Reform at the Brookings Institution, Dr. Glen Forbes, CEO of the Mayo Clinic's Rochester Campus, as well as MIT faculty members Richard Larson, Nancy Leveson and Debbie Nightingale.
The discussion will be moderated by Dr. Garry Neil, corporate vice president, Corporate Office of Science and Technology at Johnson & Johnson. To RSVP e-mail firstname.lastname@example.org or call 617-253-0902.